drugset / Trial / NCT03886766

Bioavailability Mechanistic Study of Hot-Melt Extruded Amorphous Solid Dispersions

NCT03886766

RandomizedCrossoverOpen-labelBasic science

Summary

It is the aim of the study to investigate the functioning of a drug delivery system (drug-rich particles forming hot-melt extruded amorphous solid dispersions) with respect to mechanisms of bioavailability of poorly soluble drug substances.

Timeline

Start
2019-04-30
Primary completion
2020-03-19
Completion
2020-03-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Efavirenz Other / unclassified 3 mg Oral
Subject Efavirenz Other / unclassified 50 mg Oral

Indications

No indication recorded.